Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
4,95 USD | +8,08 % | +16,75 % | +5,32 % |
Métier
Nombre d'employés: 37
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Matthew Pauls
CEO | Chief Executive Officer | 53 | 27/04/17 |
David Lowrance
DFI | Director of Finance/CFO | 56 | 27/04/17 |
Robert M. Lutz
COO | Chief Operating Officer | 55 | 13/02/23 |
Raymond Pratt
CTO | Chief Tech/Sci/R&D Officer | 73 | 10/11/22 |
Anne Erickson
IRC | Investor Relations Contact | - | 01/10/18 |
Charles LaPree
LAW | General Counsel | - | 01/08/21 |
Kate McCabe
LAW | General Counsel | - | 01/03/18 |
Scott Wilhoit
PRN | Corporate Officer/Principal | 61 | 09/01/23 |
Peter M. Clarke
PRN | Corporate Officer/Principal | 64 | 01/09/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Ramsay
BRD | Director/Board Member | 59 | 27/04/17 |
Richard Hawkins
BRD | Director/Board Member | 75 | 01/10/10 |
Nevan Elam
BRD | Director/Board Member | 56 | 01/02/09 |
Ricky Sun
BRD | Director/Board Member | 50 | 24/12/19 |
Joseph McCracken
BRD | Director/Board Member | 70 | 27/04/17 |
Matthew Pauls
CEO | Chief Executive Officer | 53 | 27/04/17 |
Director/Board Member | 64 | 03/12/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 138 176 641 | 130 399 382 ( 94,37 %) | 0 | 94,37 % |
Coordonnées société
Savara, Inc.
1717 Langhorne Newtown Road Suite 302
19047, Langhorne
+(512) 614-1848
http://www.savarapharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+5,32 % | 684 M | |
-1,17 % | 104 Md | |
+2,87 % | 97,47 Md | |
+2,13 % | 22,25 Md | |
-14,77 % | 21,68 Md | |
-8,79 % | 18,2 Md | |
-39,98 % | 17,02 Md | |
-13,21 % | 16,36 Md | |
+8,55 % | 14,39 Md | |
+35,75 % | 12,37 Md |
- Bourse
- Actions
- Action SVRA
- Société Savara Inc.